2021 annual financial data
Oramed Pharmaceuticals 2021 Operating cash flow
Direct answer
Operating cash flow was -21,181,000 USD.
Operating income was -24,223,000 USD and net income was -22,238,000 USD.
Operating cash flow was -21,181,000 USD.
Get free Oramed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,703,000 USD
- Operating income
- -24,223,000 USD
- Net income
- -22,238,000 USD
- Operating cash flow
- -21,181,000 USD